Therapeutic Landscape of Carfilzomib and Other Modulators of the Ubiquitin-Proteasome Pathway

被引：15
作者：
Mitsiades, Constantine S. [1 ,2 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 07期
基金：
美国国家卫生研究院;
关键词：
LOW-DOSE DEXAMETHASONE; REFRACTORY MULTIPLE-MYELOMA; PHASE-I TRIAL; PROTEIN-DEGRADATION; WALDENSTROMS MACROGLOBULINEMIA; IRREVERSIBLE INHIBITOR; PRECLINICAL MODELS; ANTITUMOR-ACTIVITY; QUALITY-CONTROL; AL AMYLOIDOSIS;
D O I：
10.1200/JCO.2014.55.5748
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：782 / 785
页数：4
相关论文
共 76 条
[71]  
Stewart AK, 2014, N ENGL J MED
[72]   The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective [J].
Su, Huabo ;
Wang, Xuejun .
CARDIOVASCULAR RESEARCH, 2010, 85 (02) :253-262
[73]   A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance [J].
Tian, Ze ;
D'Arcy, Padraig ;
Wang, Xin ;
Ray, Arghya ;
Tai, Yu-Tzu ;
Hu, Yiguo ;
Carrasco, Ruben D. ;
Richardson, Paul ;
Linder, Stig ;
Chauhan, Dharminder ;
Anderson, Kenneth C. .
BLOOD, 2014, 123 (05) :706-716
[74]   Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: Results of WMCTG trial 03-248 [J].
Treon, Steven P. ;
Hunter, Zachary R. ;
Matous, Jeffrey ;
Joyce, Robin M. ;
Mannion, Brian ;
Advani, Ranjana ;
Cook, David ;
Songer, Joseph ;
Hill, John ;
Kaden, Bruce R. ;
Sharon, David ;
Steiss, Ronald ;
Leleu, Xavier ;
Branagan, Andrew R. ;
Badros, Ashraf .
CLINICAL CANCER RESEARCH, 2007, 13 (11) :3320-3325
[75]   Phase 2 dose-expansion study (PX-171-006) of carfilzomib, lenalidomide, and low-dose dexamethasone in relapsed or progressive multiple myeloma [J].
Wang, Michael ;
Martin, Tom ;
Bensinger, William ;
Alsina, Melissa ;
Siegel, David S. ;
Kavalerchik, Edward ;
Huang, Mei ;
Orlowski, Robert Z. ;
Niesvizky, Ruben .
BLOOD, 2013, 122 (18) :3122-3128
[76]   The 19S Deubiquitinase Inhibitor b-AP15 Is Enriched in Cells and Elicits Rapid Commitment to Cell Death [J].
Wang, Xin ;
Stafford, William ;
Mazurkiewicz, Magdalena ;
Fryknas, Marten ;
Brjnic, Slavica ;
Zhang, Xiaonan ;
Gullbo, Joachim ;
Larsson, Rolf ;
Arner, Elias S. J. ;
D'Arcy, Padraig ;
Linder, Stig .
MOLECULAR PHARMACOLOGY, 2014, 85 (06) :932-945
12345678